A new type of artificial heart by French company Carmat, that uses valves made from cow heart tissue, and combines biological materials and synthetic with sensors. Images © Carmat
The new artificial heart, a “bioprosthetic” device that combines biology with machinery, has also a software to detect patient’s level of exertion and adjust output accordingly.
Now will be tested in patients at four cardiac surgery centers in Europe and the Middle East.
William Cohn, a heart surgeon at the Texas Heart Institute in Houston, said:
“It’s a brilliant device; I just worry about the size and mechanical durability. A device that lasts two to three years is, at best, a stopgap for transplant.”
Read more MIT Technology Review